Industry Update: Biotechnology

IBiotech industry updatendustry Highlights

  • On September 14, 2021, Sanofi announced the completion of its $3.2 billion acquisition of Translate Bio, further accelerating the company’s efforts to develop transformative vaccines and therapies using mRNA technology. With the acquisition, Translate Bio will continue as a surviving corporation and work as an indirect, fully owned unit of Sanofi.
  • On July 21, 2021, AstraZeneca completed the $46 billion acquisition of Alexion Pharmaceuticals, Inc. AstraZeneca now has an enhanced scientific presence in immunology and, through Alexion’s innovative complement-biology platform and robust pipeline, will continue to pioneer the discovery and development of medicines for patients with rare diseases.

Past Industry Updates

More Industry Reports